At Source Genomics, we deliver high-quality clinical genomic testing designed to accelerate discovery, enable precision diagnostics, and improve patient outcomes.
Our portfolio spans oncology, virology, hereditary disease, and targeted panels, providing the genomic insights that drive both translational research and clinical decision-making. By integrating seamlessly into discovery pipelines and healthcare programmes, we empower our partners in clinics, hospitals, and private health settings to translate complex genomic data into actionable results.
As part of Source BioScience, we combine a two-decade track record in genomics with deep clinical experience and a commitment to quality, compliance, and patient safety. Using state-of-the-art platforms, including Illumina NovaSeq X Plus, NextSeq, MiSeq, Oxford Nanopore, and Element Biosciences AVITI™, our laboratories deliver reliable, accredited results trusted across research and healthcare communities.
Our Service Portfolio
Explore our range of clinically aligned genomic testing services:
Oncology – Comprehensive, disease-agnostic tumour profiling to support precision oncology.
Cancer Panels – Targeted multi-gene assays for mutation profiling, microsatellite instability (MSI), and tumour mutational burden (TMB).
Colon Cancer – NGS and PCR-based testing to support therapy selection.
Prostate Cancer – Blood-based and genomic assays (e.g., Proclarix, Stockholm3) for early detection, risk stratification, and precision trial enrolment.
Pancreatic Cancer – High-sensitivity sequencing for KRAS and related driver mutations.
Bladder Cancer – Urine-based methylation testing and mutation panels for non-invasive detection and recurrence surveillance such as EpiCheck.
Lung Cancer– EGFR, ALK, ROS1, and broad NGS panels for therapy prediction, resistance monitoring, and cfDNA liquid biopsy analysis.
Breast Cancer– BRCA1/2 germline testing, PIK3CA and HER2 tumour analysis, PD-L1 IHC, and multigene prognostic assays.
Virology – Viral genome sequencing, resistance genotyping (HIV, HBV, HCV), and quantitative viral load testing using qPCR and digital PCR.
Hereditary Disease Genomics – Germline panels and exome sequencing for inherited disease predispositions, family variant testing, and carrier screening.
Explore our testing services below or contact our scientific team to discuss how our genomic solutions can support your research and clinical programmes.
Why Partner With Us?
Accredited Quality and Compliance
All testing is performed in ISO 9001:2015 and ISO 15189:2022 accredited, UKAS-certified laboratories. Our facilities operate under Good Clinical Practice (GCP) and Human Tissue Authority (HTA) frameworks, ensuring the highest standards of sample integrity, traceability, and patient safety. Every result we produce meets the stringent requirements for both research reproducibility and clinical confidence.
Scientific Expertise and Data Integrity
We understand that turnaround time is critical for patient care. As market leaders in rapid genomic analysis, our streamlined NGS workflows deliver high-depth data within days, empowering clinicians to make accurate diagnoses within clinically actionable timelines. Every project benefits from automated LIMS tracking and secure, clinician-ready data delivery.
Speed without Compromise
With more than 20 years of genomic experience, our scientists and RCPath-qualified pathologists apply rigorous quality controls to deliver precise, reproducible data.
Customisation and Scalability
From single-gene tests to whole-genome sequencing and multi-omics integration, our services scale to meet your study size and complexity. We design and validate custom panels for unique biomarkers or therapeutic targets, adapting seamlessly to the needs of biotech, academic, and clinical partners.
Integrated Data Delivery and Reporting
Receive your data in publication- and submission-ready formats: FASTQ, BAM, VCF, CSV, and JSON. We provide variant-annotated, interpretation-ready reports that align with regulatory standards. Through Relyter, our secure online genome browser, you can visualise and explore variants interactively, without requiring an in-house bioinformatics team.
Local Expertise
Receive your data in publication- and submission-ready formats: FASTQ, BAM, VCF, CSV, and JSON. We provide variant-annotated, interpretation-ready reports that align with regulatory standards. Through Relyter, our secure online genome browser, you can visualise and explore variants interactively, without requiring an in-house bioinformatics team.
Clinical and Translational Impact
Our genomic testing services bridge laboratory science and clinical application. By generating accurate, validated data, we help partners:
Source Genomics combines technical excellence with clinical credibility, helping healthcare providers translate genomic data into real-world impact. Every project reflects our commitment to quality, compliance, and the advancement of precision medicine. Contact us today to learn more about our clinical genomic testing services.
Explore our testing services below or contact our scientific team to discuss how our genomic solutions can support your research and clinical programmes.